Results 171 to 180 of about 298,990 (256)

Retraction of: P-1835. Dual burden of infections: seroprevalence of acute viral hepatitis among dengue patients in northern India. [PDF]

Open Forum Infect Dis
europepmc   +1 more source

Assessing the global burden of acute viral hepatitis in the elderly: a comprehensive analysis of data from the GBD 2021 database. [PDF]

BMC Infect Dis
Xing T, Wu H, Li A, Shao H, Qu H, Ding J, Wang X.   +6 more
europepmc   +1 more source

National trends in acute viral hepatitis in China from 1990-2023: An analysis of the Global Burden of Disease 2023 update. [PDF]

Chin Med J (Engl)
Jiao J, Che X, Tang H, Wang W, Zhao R, Song Q, Xu M, Chen Y.   +7 more
europepmc   +1 more source

Epigenetic Regulation in the Pathogenesis of Renal Inflammation: Insights and Therapeutic Potentials

iNew Medicine, EarlyView.
ABSTRACT Renal inflammation is a common pathological process in various kidney diseases, often initiated by factors such as toxins, ischemia, or autoimmune reactions. This inflammatory response can result in structural damage and a rapid decline in renal function.
Yu‐Hang Dong, Xiao‐Yu Shen, Han‐Cheng Jin, Xiang‐Yu Li, Hao He, Xiao‐Ming Meng   +5 more
wiley   +1 more source

Elimination of chronic viral hepatitis C in correctional health. [PDF]

Singapore Med J
Kumar R, Wong YJ, Tan J.
europepmc   +1 more source

The T‐Cell Response Mechanism in Human Papillomavirus‐Associated Cervical Cancer and New Strategies for Immunotherapy

iNew Medicine, EarlyView.
ABSTRACT Human papillomavirus (HPV) is a double‐stranded DNA virus that infects human skin and mucosal tissues exclusively. The German scientist Harald zur Hausen was awarded the 2008 Nobel Prize in Physiology or Medicine for his discovery of the link between HPV infection and cervical cancer.
Fang Zhu, Farah Nazir, Ying Zhou, Yuhua Shang, Hongliang He, Tengchuan Jin   +5 more
wiley   +1 more source

Challenges and opportunities in combating viral hepatitis in India: insights from the Indian Hepatitis Summit 2025. [PDF]

BMC Proc
Shanmugam V, Ward J, Vijayakumar S, Khwairakpam G, James C, Shanmugam L, Girija V, Rewari BB.   +7 more
europepmc   +1 more source

Serum Midkine as a Biomarker for Hepatocellular Carcinoma Treatment Response and Prognostication

Journal of Clinical Laboratory Analysis, EarlyView.
Up‐to‐date, tumor markers are considered more helpful in the evaluation of treatment response and prognostication rather than diagnosis. Identifying a valid biomarker to help clinical management of hepatocellular carcinoma (HCC) is still a challenge, especially the alpha‐fetoprotein (AFP) negative HCC. This study evaluated the efficacy of serum Midkine
Yanfang Luo, Qiuwei Lu, Jing Huang, Liejun Jiang   +3 more
wiley   +1 more source

Evolving insights into viral hepatitis: Advances, evidence, and expert perspectives from the ESCMID Study Group for Viral Hepatitis (ESGVH) - Part 2: hepatitis B, C, and delta. [PDF]

Germs
Săndulescu O, Matičič M, Garcia F, Blomé MA, Mondelli MU, Irving W, Zidovec-Lepej S, Widell A, Şahin GÖ, ESCMID Study Group for Viral Hepatitis (ESGVH).   +9 more
europepmc   +1 more source